The 5-HT 7 receptor antagonist SB 269970 counteracts restraint stress-induced attenuation of long-term potentiation in rat frontal cortex

Journal of Physiology and Pharmacology

Volumn 62, Issue 6, 2011, Pages 663-667

  Tokarski, K ^a   Bobula, B ^a   Kusek, M ^a,b   Hess, G ^a,b  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Adaptive changes; Brain; Frontal cortex; Glutamate; Long term potentiation; Serotonin receptor antagonist; Stress

Indexed keywords

3 [2 [2 (4 METHYL 1 PIPERIDINYL)ETHYL] 1 PYRROLIDINESULFONYL]PHENOL; SEROTONIN 7 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; ELECTRIC POTENTIAL; EXTRACELLULAR FIELD POTENTIAL; FRONTAL CORTEX; GLUTAMATERGIC TRANSMISSION; IMMOBILIZATION STRESS; LONG TERM POTENTIATION; NERVE CELL PLASTICITY; NEUROTRANSMISSION; NONHUMAN; RAT;

ANIMALS; FRONTAL LOBE; LONG-TERM POTENTIATION; MALE; PHENOLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; RESTRAINT, PHYSICAL; SEROTONIN ANTAGONISTS; STRESS, PSYCHOLOGICAL; SULFONAMIDES;

EID: 84856841446     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Checkley S. The neuroendocrinology of depression and chronic stress. Br Med Bull 1996; 52: 597-617.
2. Lopez JF, Chalmers DT, Little K Y, Watson SJ. A.E. Bennett Research Award. Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression. Biol Psychiatry 1998; 43: 547-573.
3. Parker KJ, Schatzberg AF, Lyons DM. Neuroendocrine aspects of hypercortisolism in major depression. Horm Behav 2003; 43: 60-66.
4. Musazzi L, Racagni G, Popoli M. Stress, glucocorticoids and glutamate release: effects of antidepressant drugs. Neurochem Int 2011; 59: 896-905.
5. Paul IA, Skolnick P. Glutamate and depression: clinical and preclinical studies. Ann NY Acad Sci 2003; 1003: 250-272.
6. Kugaya A, Sanacora G. Beyond monoamines: glutamatergic function in mood disorders. CNS Spectr 2005; 10: 808-819.
7. Palucha A, Pilc A. The involvement of glutamate in the pathophysiology of depression. Drug News Perspect 2005; 18: 262-268.
8. Zarate C, Machado-Vieira R, Henter I, Ibrahim L, Diazgranados N, Salvadore G. Glutamatergic modulators: the future of treating mood disorders? Harv Rev Psychiatry 2010; 18: 293-303.
9. Murrough JW, Iacoviello B, Neumeister A, Charney DS, Iosifescu D V. Cognitive dysfunction in depression: neurocircuitry and new therapeutic strategies. Neurobiol Learn Mem 2011; 96: 553-563.
10. Bobula B, Wabno J, Hess G. Imipramine counteracts corticosterone-induced enhancement of glutamatergic transmission and impairment of long-term potentiation in rat frontal cortex. Pharmacol Rep 2011; 63: 1404-1412.
11. Mann JJ. Role of the serotonergic system in the pathogenesis of major depression and suicidal behavior. Neuropsychopharmacology 1999; 21 (Suppl 1): 99S-105S.
12. Hedlund PB, Sutcliffe J G. Functional, molecular and pharmacological advances in 5-HT7 receptor research. Trends Pharmacol Sci 2004; 25: 481-486.
13. Thomas DR, Hagan JJ. 5-HT7 receptors. Curr Drug Targets CNS Neurol Disord 2004; 3: 81-90.
14. Tokarski K, Pitra P, Duszynska B, Hess G. Imipramine counteracts corticosterone-induced alterations in the effects of the activation of 5-HT7 receptors in rat hippocampus. J Physiol Pharmacol 2009; 60: 83-88.
15. Abbas AI, Hedlund PB, Huang XP, Tran TB, Meltzer HY, Roth BL. Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo. Psychopharmacology (Berl) 2009; 205: 119-128.
16. Hedlund PB, Huitron-Resendiz S, Henriksen SJ, Sutcliffe J G. 5-HT7 receptor inhibition and inactivation induce antidepressant-like behavior and sleep pattern. Biol Psychiatry 2005; 58: 831-837.
17. Wesolowska A, Nikiforuk A, Stachowicz K. Potential anxiolytic and antidepressant effects of the selective 5-HT7 receptor antagonist SB 269970 after intrahippocampal administration to rats. Eur J Pharmacol 2006; 553: 185-190.
18. Bonaventure P, Kelly L, Aluisio L, et al. Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents. J Pharmacol Exp Ther 2007; 321: 690-698.
19. Wesolowska A, Tatarczynska E, Nikiforuk A, Chojnacka-Wojcik E. Enhancement of the anti-immobility action of antidepressants by a selective 5-HT7 receptor antagonist in the forced swimming test in mice. Eur J Pharmacol 2007; 555: 43-47.
20. Mnie-Filali O, Lambas-Senas L, Zimmer L, Haddjeri N. 5-HT7 receptor antagonists as a new class of antidepressants. Drug News Perspect 2007; 20: 613-618.
21. Nikiforuk A. Selective blockade of 5-HT7 receptors facilitates attentional set-shifting in stressed and control rats. Behav Brain Res 2012; 226: 118-123.
22. Gadek-Michalska A, Bugajski J. Repeated handling, restraint, or chronic crowding impair the hypothalamic-pituitary-adrenocortical response to acute restraint stress. J Physiol Pharmacol 2003; 54: 449-459.
23. Bobula B, Tokarski K, Hess G. Repeated administration of antidepressants decreases field potentials in rat frontal cortex. Brain Res 2003; 93: 230-234.
24. Tokarski K, Bobula B, Wabno J, Hess G. Repeated administration of imipramine attenuates glutamatergic transmission in rat frontal cortex. Neuroscience 2008; 53: 789-795.
25. Groeneweg FL, Karst H, de Kloet ER, Joels M. Rapid non-genomic effects of corticosteroids and their role in the central stress response. J Endocrinol 2011; 209: 153-167.
26. Joels M, Krugers HJ, Lucassen PJ, Karst H. Corticosteroid effects on cellular physiology of limbic cells. Brain Res 2009; 293: 91-100.
27. Spyrka J, Danielewicz J, Hess G. Brief neck restraint stress enhances long-term potentiation and suppresses long-term depression in the dentate gyrus of the mouse. Brain Res Bull 2011; 85: 363-367.
28. Spyrka J, Hess G. Repeated restraint-induced modulation of long-term potentiation in the dentate gyrus of the mouse. Brain Res 2010; 1320: 28-33.
29. Fontella FU, Vendite DA, Tabajara AS, et al. Repeated restraint stress alters hippocampal glutamate uptake and release in the rat. Neurochem Res 2004; 29: 1703-1709.
30. Yamamoto B, Reagan LP. The glutamatergic system in neuronal plasticity and vulnerability in mood disorders. Neuropsych Dis Treat 2006; 2(Suppl. 2): 7-14.
31. Joels M, Karst H, Alfarez D, et al. Effects of chronic stress on structure and cell function in rat hippocampus and hypothalamus. Stress 2004; 7: 221-231.
32. Yuen EY, Liu W, Karatsoreos IN, Feng J, McEwen BS, Yan Z. Acute stress enhances glutamatergic transmission in prefrontal cortex and facilitates working memory. Proc Natl Acad Sci USA 2009; 106: 14075-14079.
33. Yuen E Y, Liu W, Karatsoreos IN, et al. Mechanisms for acute stress-induced enhancement of glutamatergic transmission and working memory. Mol Psychiatry 2011; 16: 156-170.
34. Musazzi L, Milanese M, Farisello P, et al. Acute stress increases depolarization-evoked glutamate release in the rat prefrontal/frontal cortex: the dampening action of antidepressants. PLoS One 2010; 5: e8566.
35. Ago Y, Arikawa S, Yata M, et al. Antidepressant-like effects of the glucocorticoid receptor antagonist RU-43044 are associated with changes in prefrontal dopamine in mouse models of depression. Neuropharmacology 2008; 55: 1355-1363.
36. Pittenger C, Duman RS. Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 2008; 33: 88-109.
37. Wesolowska A, Kowalska M. Influence of serotonin 5-HT7 receptor blockade on the behavioral and neurochemical effects of imipramine in rats. Pharmacol Rep 2008; 60: 464-474.
38. Harsing L G, Prauda I, Barkoczy J, Matyus P, Juranyi Z. A 5-HT7 heteroreceptor-mediated inhibition of [3H]serotonin release in raphe nuclei slices of the rat: evidence for a serotonergic-glutamatergic interaction. Neurochem Res 2004; 29: 1487-1497.
39. Roberts C, Thomas DR, Bate ST, Kew JN. GABAergic modulation of 5-HT7 receptor-mediated effects on 5-HT efflux in the guinea-pig dorsal raphe nucleus. Neuropharmacology 2004; 46: 935-941.
40. Beaulieu JM. A role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental health. J Psychiatry Neurosci 2012; 37: 7-16.
41. Polter AM, Li X. Glycogen synthase kinase-3 is an intermediate modulator of serotonin neurotransmission. Front Mol Neurosci 2011; 4: 31.
42. Zhu LQ, Liu D, Hu J, et al. GSK-3 beta inhibits presynaptic vesicle exocytosis by phosphorylating P/Q-type calcium channel and interrupting SNARE complex formation. J Neurosci 2010; 30: 3624-3633.
43. Sotiropoulos I, Catania C, Riedemann T, et al. Glucocorticoids trigger Alzheimer disease-like pathobiochemistry in rat neuronal cells expressing human tau. J Neurochem 2008; 107: 385-397.
44. Szymanska M, Suska A, Budziszewska B, et al. Prenatal stress decreases glycogen synthase kinase-3 phosphorylation in the rat frontal cortex. Pharmacol Rep 2009; 61: 612-620.